Similar articles

• Human gene therapy research: technological temptations and social control.

  Baram M, Proctor S, Andalman R, van Eyl D. Baram M, et al. Genetic Resour. 1993;7(2):10-5. Genetic Resour. 1993. PMID: 11656942 No abstract available.
• The case for cloning.

  Nash JM. Nash JM. Time. 1998 Feb 9;151(5):81. Time. 1998. PMID: 11656707 No abstract available.
• Gene therapy in mental retardation: ethical considerations.

  Fletcher JC. Fletcher JC. Ment Retard Dev Disabil Res Rev. 1995;1:7-13. doi: 10.1002/mrdd.1410010105. Ment Retard Dev Disabil Res Rev. 1995. PMID: 11660293 No abstract available.
• Animal cloning and the FDA--the risk assessment paradigm under public scrutiny.

  Rudenko L, Matheson JC, Sundlof SF. Rudenko L, et al. Nat Biotechnol. 2007 Jan;25(1):39-43. doi: 10.1038/nbt0107-39. Nat Biotechnol. 2007. PMID: 17211392 Review.
• Targeted mutagenesis: analysis of phenotype without germ line transmission.

  Nagy A, Rossant J. Nagy A, et al. J Clin Invest. 1996 Mar 15;97(6):1360-5. doi: 10.1172/JCI118555. J Clin Invest. 1996. PMID: 8617866 Free PMC article. Review.